Contents
1. The overview of “Illumina”
2. The detailed data of “Illumina”
3. The map of “Illumina”
4. The stock weekly chart of “Illumina”
5. The stock weekly trading radar of “Illumina”
6. The annual filings of “Illumina”
7. The stock price of “Illumina”
* Last update: February 23, 2022
The overview of “Illumina”
“Illumina, Inc.” was founded in San Diego, California, the U.S. in April 1998 as a company managing the business regarding genetic information analysis. The company develops, manufactures and sells the integrated systems for the analysis of genetic variation and biological function etc, and in July 2000 was listed on NASDAQ market. Also, Illumina acquired “Solexa, Inc.” in the U.K. on January 26, 2007 and “Epicentre Biotechnologies” that based in Madison, Wisconsin, on January 11, 2011.
Currently, the company provides genetic analysis services to DNA sequencing, Genotyping and Gene expression, and Proteomics markets. Particularly, their services are utilized in several fields such as Genomic research centers, Pharmaceutical companies, Academic institutions, Government institutions, Clinical research organizations, and Biotechnology companies etc.
The detailed data of “Illumina”
●Established date： April 1998
●Location： 5200 Illumina Way, San Diego, CA 92122
●Stock Exchange： NASDAQ（ILMN）
●Listing date： July 2000
●Business details： Gene Analysis System（Biotechnlogy）
●Official website： https://www.illumina.com/
The map of “Illumina”
The stock weekly chart of “Illumina”
The stock weekly trading radar of “Illumina”
The annual filings of “Illumina”
* Date: Feb 11, 2020
* Date: Feb 12, 2019
* in millions USD
| Cutoff date | January 3, 2021 | December 29, 2019 | December 30, 2018 | December 31, 2017 |
|---|---|---|---|---|
| Operating income | 580 | 985 | 883 | 606 |
| Net income attributable | 656 | 1,002 | 826 | 726 |
| Total current assets | 4,483 | 4,451 | 4,490 | 2,980 |
| Total current liabilities | 1,244 | 665 | 1,804 | 746 |
| Current ratio (1.2 or more is the best) | 3.60 | 6.69 | 2.49 | 3.99 |
| Common stock and additional paid-in capital | 3,817 | 3,562 | 3,292 | 2,835 |
| Treasury stock | (3,848) | (3,021) | (2,616) | (2,341) |
| Retained earning, Accumulated deficit | 4,723 | 4,067 | 3,083 | 2,256 |
| Total stockholders' equity | 4,694 | 4,613 | 3,845 | 2,749 |
| Total equity and liabilities | 7,585 | 7,316 | 6,959 | 5,257 |
| Equity ratio (20% or more is better) (50% or more is the best) | 61.89% | 63.05% | 55.25% | 52.29% |
| Cash flows from operating activities | 1,080 | 1,051 | 1,142 | 875 |
| Cash flows from investing activities | (554) | 745 | (1,813) | (214) |
| Cash flows from financing activities | (766) | (897) | 594 | (176) |
| Free cash flow | 526 | 1,796 | (671) | 661 |
The stock price of “Illumina”
Net income declined, but Retained earning increased.
Also, Current ratio has exceeded the standard value for 3 years in a row, and their payment ability is always high level.
In addition to this, Illumina might be a good company because Equity ratio are high level.
* Comment
Net income and Retained earning increased.
Also, Current ratio has exceeded the standard value extremely, and their payment ability is always high level.
In addition to this, Illumina might be a good company because Equity ratio ascended.
Whereas, the company received dividend of available-for-sale securities and reduced additional purchasing.
That's why, Free cash flow turned positive.
* Comment
Net income and Retained earning increased.
Current ratio decreased, but it's still good situation.
Also, Equity ratio is quite good value.
However, Free cash flow turned negative.
The stock price in 2019 is likely to move sideways.
| Term year | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|
| Entity min stock price in monthly chart | N/A | approx 366 (Dec) | approx 265 (Feb) | approx 280 (Feb) | approx 225 (Jan) |
| Entity max stock price in monthly chart | N/A | approx 498 (Aug) | approx 385 (Aug) | approx 371 (Jul) | approx 369 (Oct) |
| Stock price increase ratio (50% or more is the best) | N/A | (36.07)% | 45.28% | 32.50% | 64.00% |
